Beijing Liangyuan Biomedical Research Co., Ltd. announced that it will receive CNY 50,000,000 in a round of funding on August 28, 2023. The transaction will includes participation from new investor Boai NKY Medical Holdings Ltd for 23.81% stake. The company has entered into investment agreement with the new investor in the transaction.

Out of total capital increase, CNY 446,429 will goes to registered capital of the company. Post capital increase, the registered capital of the company will increase from CNY 1,428,572 to CNY 1,875,000. The transaction has been approved by the board of director of the investor in its 4th Meeting of the 5th Directorate.

The transaction does not need the shareholders? approval.